Servocarelifesciences

Servocare Lifesciences Pvt Ltd


Address : S. C. F. No. 246 Motor Market, Manimajra.Chandigarh – 160 101


We are a prominent pharmaceutical company engrossed in manufacturing, supplier of cardiac-diabetic-medicine ISO-9001 : 2008 Certified company.. ….

Send Enquiry More Details

[contact-form-7 404 "Not Found"]

Genesis Biotec Inc


Address : S.C.F 437, M.M, MANIMAJRA,CHANDIGARH 160101 (U.T.)


Genesis Biotec Inc. is a Top Pharma franchise company having diversified interests in Medicine marketing, Medicine manufacturing, research and development in the areas of neutraceuticals and pharmaceuticals…….

Send Enquiry More Details

[contact-form-7 404 "Not Found"]

Cureways Remedies


Address : #47/1, P.W.T, Manimajra, Chandigarh (INDIA)


Cureways Remedies is Best pharma franchise company a professionally managed pharmaceutical company; aim to become a top pharmaceutical company….

Send Enquiry More Details

[contact-form-7 404 "Not Found"]

Maksun Biotech Pvt Ltd


Address :SCO.1,2,3, Near Supari Factory, Nanhera Road,Kuldeep Nagar, Ambala Cantt. Ambala Cantt – 133001.
Haryana, INDIA


We also attribute our success to our team of expert and skilled professionals who work round the clock and think of ingenious ways to create formulations… ….

Send Enquiry More Details

[contact-form-7 404 "Not Found"]

Dcardimax


Address : SCF – 1013, Hall 1, 2nd Floor, Motor Market, Manimajra,Chandigarh


D-Cardimax ,expertise in CARDIO & DIABETIC Drugs & Formulations. Our formulation development team and regulatory department are focused on bringing latest molecules to our markets with expedience thereby guaranteeing a constant flow of the latest products to our customers…..

Send Enquiry More Details

[contact-form-7 404 "Not Found"]

Metamorf Lifesciences


Address : 495 2nd floor, MOTOR MARKET MANIMAJRA, CHANDIGARH (UT)-160101


Metamorf Lifesciences is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. ….

Send Enquiry More Details

[contact-form-7 404 "Not Found"]

Voglibose 0.3Mg Tablets Suppliers, Third party manufacturers, Pharma Pcd Companies or pharmaceutical franchise company | India |

Looking for Voglibose 0.3 Mg Tablets Suppliers, Third party manufacturers, Pharma Pcd Companies or pharmaceutical franchise company.

Cardiac Diabetic medicine dot com is a market place where you can find right pharma pcd company or pharma franchise company for Voglibose 0.3Mg Tablets In India. Thes pharma pcd companies are offering pharma propaganda cum marketing monopoly rights in their vacant areas.

Cardiac Diabetic Products Composition :- voglibose 0.2mg Tablets

PACKING:-10×10

Voglibose 0.3mg in tablets form (INN and USAN) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus.

VOGLIBOSE 0.3MG Tablets Pharmacology:

  1. VOGLIBOSE 0.3MG Tablets PHARMACODYNAMICS:-

Voglibose, an alpha-glucosidase inhibitor, is a synthetic compound with potent and enduring therapeutic efficacies against disorders of sensory, motor and autonomic nerve systems due to diabetes mellitus. The drug was approved in Japan in 1994 for the treatment of diabetes, and it is under further investigation by Takeda for the treatment of impaired glucose tolerance. Alpha-glucosidase inhibitors are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of complex carbohydrates (such as starch). Complex carbohydrates are normally converted into simple sugars (monosaccharides) which can be absorbed through the intestine. Hence, alpha-glucosidase inhibitors reduce the impact of complex carbohydrates on blood sugar.

MECHANISM OF ACTION:-Alpha-glucosidase inhibitors are saccharides that act as competitive inhibitors of enzymes needed to digest carbohydrates: specifically alpha-glucosidase enzymes in the brush border of the small intestines. The membrane-bound intestinal alpha-glucosidases hydrolyze oligosaccharides, trisaccharides, and disaccharides to glucose and other monosaccharides in the small intestine. Acarbose also blocks pancreatic alpha-amylase in addition to inhibiting membrane-bound alpha-glucosidases. Pancreatic alpha-amylase hydrolyzes complex starches to oligosaccharides in the lumen of the small intestine. Inhibition of these enzyme systems reduces the rate of digestion of complex carbohydrates. Less glucose is absorbed because the carbohydrates are not broken down into glucose molecules. In diabetic patients, the short-term effect of these drugs therapies is to decrease current blood glucose levels: the long term effect is a small reduction in hemoglobin-A1c level.

  1. VOGLIBOSE 0.3MG TABLETS PHARMACOKINETICS:-
  • VOGLIBOSE 0.3MG ABSORPTION:  – Slowly and poorly absorbed
  • VOGLIBOSE 0.3MG METABOLISM: –  Little metabolism occurs and no metabolites have as yet been identified.
  • VOGLIBOSE 0.3MG AFFECTED ORGANISMS:  – Humans and other mammals

INDICATIONS FOR VOGLIBOSE 0.3MG TABLETS

  • For the treatment of diabetes.
  • It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications

Enquire for to find best pcd pharma franchise company or third party manufacturers for

Cardiac Diabetic Products Composition :- voglibose 0.3mg Tablets

PACKING:-10×10

Voglibose 0.2mg in tablets form (INN and USAN) is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus.

VOGLIBOSE 0.3MG Tablets Pharmacology:

  1. VOGLIBOSE 0.3MG Tablets PHARMACODYNAMICS:-

Voglibose, an alpha-glucosidase inhibitor, is a synthetic compound with potent and enduring therapeutic efficacies against disorders of sensory, motor and autonomic nerve systems due to diabetes mellitus. The drug was approved in Japan in 1994 for the treatment of diabetes, and it is under further investigation by Takeda for the treatment of impaired glucose tolerance. Alpha-glucosidase inhibitors are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of complex carbohydrates (such as starch). Complex carbohydrates are normally converted into simple sugars (monosaccharides) which can be absorbed through the intestine. Hence, alpha-glucosidase inhibitors reduce the impact of complex carbohydrates on blood sugar.

Voglibose 0.3Mg Tablets MECHANISM OF ACTION :- Alpha-glucosidase inhibitors are saccharides that act as competitive inhibitors of enzymes needed to digest carbohydrates: specifically alpha-glucosidase enzymes in the brush border of the small intestines. The membrane-bound intestinal alpha-glucosidases hydrolyze oligosaccharides, trisaccharides, and disaccharides to glucose and other monosaccharides in the small intestine. Acarbose also blocks pancreatic alpha-amylase in addition to inhibiting membrane-bound alpha-glucosidases. Pancreatic alpha-amylase hydrolyzes complex starches to oligosaccharides in the lumen of the small intestine. Inhibition of these enzyme systems reduces the rate of digestion of complex carbohydrates. Less glucose is absorbed because the carbohydrates are not broken down into glucose molecules. In diabetic patients, the short-term effect of these drugs therapies is to decrease current blood glucose levels: the long term effect is a small reduction in hemoglobin-A1c level.

  1. VOGLIBOSE 0.3MG TABLETS PHARMACOKINETICS:-
  • VOGLIBOSE 0.3MG ABSORPTION:  – Slowly and poorly absorbed
  • VOGLIBOSE 0.3MG METABOLISM: –  Little metabolism occurs and no metabolites have as yet been identified.
  • VOGLIBOSE 0.3MG AFFECTED ORGANISMS:  – Humans and other mammals

INDICATIONS FOR VOGLIBOSE 0.3MG TABLETS

  • For the treatment of diabetes.
  • It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications